Evidence-Based Policymaking

This Annual Evaluation Plan is one of several required Evidence Act products, including the 4-year Evidence-Building Plan (also referred to as the Learning Agenda), Capacity Assessment, and agency Evaluation Policy. The FY2023 Evaluation Plan priority areas are aligned with the goals of the FY 2022-2026 HHS Strategic Plan and the FY 2023- 2026 HHS Evidence-Building Plan.

Under the Foundations for Evidence-Based Policymaking Act of 2018 (Evidence Act), the Capacity Assessment requires agencies to assess the coverage, quality, methods, effectiveness, and independence of their statistics, evaluation, research, and analysis efforts.

The HHS Evidence Building Plan, required by the Evidence Act, is a systematic plan for identifying and addressing policy questions relevant to the programs, policies, and regulations of the agency.

Market-based payment policies such as competitive bidding, reference pricing, centers of excellence and tiered provider networks have been implemented both in Medicare and across the private sector, as described in this report required by Executive Order 13890.

This paper examines the combined effects of drug plan risk the first year of Medicare part D implementation of the combination of reinsurance, risk-adjustment and risk-corridors

By: Kathryn L.S. Pettit, G. Thomas Kingsley, and Claudia J. Coulton With Jessica Cigna Submitted to: The Office of the Assistant Secretary for Planning and Evaluation U.S. Department of Health and Human Services